| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |